Actuate Therapeutics (ACTU) said late Tuesday it plans a public offering of common shares.
The company intends to grant underwriters a 30-day overallotment option to buy up to an additional 15% of the shares.
The company said it plans to use net proceeds for general corporate purposes.
Shares of Actuate Therapeutics were down more than 16% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments